Palisade Bio Statistics
NASDAQ: PALIHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.48-0.01 (-0.67%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.46 -1.09%
Palisade Bio by the numbers
Palisade Bio has a market capitalization of $257.9 million based on 174.27M shares outstanding. Its trailing P/E ratio is 2.5. The stock trades 21.7% below its 50-day average and 22.6% below its 200-day average.
Average daily trading volume is 2.60M shares, or about $3.9 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PALI valuation vs. peer median
| Metric | PALI | Peer median | Difference |
|---|---|---|---|
| Market cap | $257.92M | $259.83M | -1% |
| Avg. volume | 2.60M | 749.76K | +247% |
Peer median across 8 companies: FATE, SABS, IKT, LXEO, STRO, XFOR, LCTX, IPSC.
Valuation
- Market cap
- $257.92M
- P/E (TTM)
- 2.47
- EPS (TTM)
- $0.60
- Shares outstanding
- 174.27M
Price and trading
- Previous close
- 1.49
- Open
- 1.46
- Day range
- 1.44 – 1.48
- 52-week range
- 1.32 – 2.86
- 52-week change
- -11.90%
- Beta
- —
- Volume
- 825.23K
- Average volume
- 2.60M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 11, 2025
Additional statistics
- Market Cap
- 257.92M
- Pe
- 2.47
- Forward Pe
- -5.29
- Eps
- 0.60
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.86
- Week52 Low
- 1.32
- Avg Volume
- 2.60M
- Shares Outstanding
- 174.27M
- Ma50
- 1.89
- Ma200
- 1.91
- Earnings Date
- Aug 11, 2025
- Pct From52w High
- -48.25%
- Pct From52w Low
- 12.12%